Table 1.
Characteristics of study patients (n = 187)
| Age, years (range) | 67.2 ± 8.7 (21–83) |
| Sex (female/male) | 47 (25.1)/140 (74.9) |
| Etiology (HBV/HCV/HBV + HCV/non-HBV, non-HCV) | 31 (16.6)/123 (65.8)/2 (1.0)/31 (16.6) |
| Child-Pugh class (A/B) | 179 (95.7)/8 (4.3) |
| Albumin (g/dL) | 4.04 ± 0.42 |
| Total bilirubin (mg/dL) | 0.78 ± 0.33 |
| ICG retention rate at 15-min (%) | 15.4 ± 7.4 |
| Prothrombin (%) | 92.6 ± 14.1 |
| Platelet (×1000/mL) | 145 ± 70 |
| Tumor size, cm (range) | 3.24 ± 2.52 (0.8–16.4) |
| Number of tumors, n (range) | 1.27 ± 0.63 (1–4) |
| (single/multiple) | 153 (81.8)/34 (18.2) |
| Macroscopic portal vein invasion (absent/present)1 | 181 (96.8)/6 (3.2) |
| AFP (ng/mL); median (range) | 11.1 (0.8–27,242.8) |
| ≥20/<20 ng/mL | 67 (35.8)/120 (64.2) |
| DCP (mAU/mL); median (range) | 39.0 (5.0–60,030.0) |
| ≥40/<40 mAU/mL | 94 (50.3)/93 (49.7) |
| Conventional AFP-L3 (%); median (range) | 0.5 (0.0–87.2) |
| ≥10/<10% | 37 (19.8)/150 (80.2) |
| Highly sensitive AFP-L3 (%); median (range) | 4.8 (0.0–89.7) |
| ≥5/<5% | 85 (45.5)/102 (54.5) |
Values are means ± SD, unless otherwise indicated. Percentages are given in parentheses, unless otherwise indicated. HBV, hepatitis B virus; HCV, hepatitis C virus; ICG, indocyanine green test; AFP, alpha-fetoprotein; AFP-L3, Lens culinaris agglutinin-reactive AFP; DCP, des-gamma-carboxy prothrombin.
1
Evaluated based on imaging findings.